Articles written by: Adrian Erickson

Xinjiang Tianye Co.,Ltd (600075) Moved Up 2.9% on Feb 18

Shares of Xinjiang Tianye Co.,Ltd (SHA:600075) last traded at 4.97, representing a move of 2.9%, or 0.14 per share, on volume of 10.67 million shares. After opening the trading day at 4.87, shares of Xinjiang Tianye Co.,Ltd traded in a close range. Xinjiang Tianye Co.,Ltd currently has a total float […]

EcoBio Holdings Co., Ltd. (038870) Soared 0.94% on Feb 18

Shares of EcoBio Holdings Co., Ltd. (KOSDAQ:038870) last traded at 7540, representing a move of 0.94%, or 70 per share, on volume of 67,898 shares. After opening the trading day at 7500, shares of EcoBio Holdings Co., Ltd. traded in a close range. EcoBio Holdings Co., Ltd. currently has a […]

ConvergeOne Holdings, Inc. (CVON) EPS Estimated At $0.17

Analysts expect ConvergeOne Holdings, Inc. (NASDAQ:CVON) to report $0.17 EPS on March, 19.They anticipate $0.02 EPS change or 10.53 % from last quarter’s $0.19 EPS. CVON’s profit would be $537,154 giving it 18.29 P/E if the $0.17 EPS is correct. After having $0.30 EPS previously, ConvergeOne Holdings, Inc.’s analysts see […]

Denali Therapeutics Inc. (DNLI) Analysts See $-0.02 EPS

Denali Therapeutics Inc. (DNLI) Analysts See $-0.02 EPS

Analysts expect Denali Therapeutics Inc. (NASDAQ:DNLI) to report $-0.02 EPS on March, 18.They anticipate $0.72 EPS change or 97.30 % from last quarter’s $-0.74 EPS. After having $-0.38 EPS previously, Denali Therapeutics Inc.’s analysts see -94.74 % EPS growth. The stock increased 3.50% or $0.71 during the last trading session, […]

Analysts See $0.52 EPS for Cherry Hill Mortgage Investment Corporation (CHMI)

Analysts See $0.52 EPS for Cherry Hill Mortgage Investment Corporation (CHMI)

Investors sentiment decreased to 2.04 in 2018 Q3. Its down 0.28, from 2.32 in 2018Q2. It turned negative, as 9 investors sold Cherry Hill Mortgage Investment Corporation shares while 15 reduced holdings. 15 funds opened positions while 34 raised stakes. 8.92 million shares or 7.92% more from 8.27 million shares […]

$-0.42 EPS Expected for Abeona Therapeutics Inc. (ABEO)

$-0.42 EPS Expected for Abeona Therapeutics Inc. (ABEO)

Analysts expect Abeona Therapeutics Inc. (NASDAQ:ABEO) to report $-0.42 EPS on March, 15.They anticipate $0.23 EPS change or 121.05 % from last quarter’s $-0.19 EPS. After having $-0.34 EPS previously, Abeona Therapeutics Inc.’s analysts see 23.53 % EPS growth. The stock increased 2.00% or $0.13 during the last trading session, […]

EPS for Upland Software, Inc. (UPLD) Expected At $0.25

EPS for Upland Software, Inc. (UPLD) Expected At $0.25

Analysts expect Upland Software, Inc. (NASDAQ:UPLD) to report $0.25 EPS on March, 14.They anticipate $0.01 EPS change or 3.85 % from last quarter’s $0.26 EPS. UPLD’s profit would be $5.40M giving it 33.90 P/E if the $0.25 EPS is correct. After having $0.21 EPS previously, Upland Software, Inc.’s analysts see […]

EPS for TerraForm Power, Inc. (TERP) Expected At $-0.05

EPS for TerraForm Power, Inc. (TERP) Expected At $-0.05

Analysts expect TerraForm Power, Inc. (NASDAQ:TERP) to report $-0.05 EPS on March, 14.They anticipate $0.09 EPS change or 64.29 % from last quarter’s $-0.14 EPS. After having $-0.15 EPS previously, TerraForm Power, Inc.’s analysts see -66.67 % EPS growth. The stock increased 0.33% or $0.04 during the last trading session, […]

VIVUS, Inc. (VVUS) EPS Estimated At $-0.53

VIVUS, Inc. (VVUS) EPS Estimated At $-0.53

Analysts expect VIVUS, Inc. (NASDAQ:VVUS) to report $-0.53 EPS on March, 12.They anticipate $0.47 EPS change or 47.00 % from last quarter’s $-1 EPS. After having $-0.87 EPS previously, VIVUS, Inc.’s analysts see -39.08 % EPS growth. The stock decreased 1.92% or $0.1 during the last trading session, reaching $5.1. […]

Melinta Therapeutics, Inc. (MLNT) EPS Estimated At $-1.00

Melinta Therapeutics, Inc. (MLNT) EPS Estimated At $-1.00

Analysts expect Melinta Therapeutics, Inc. (NASDAQ:MLNT) to report $-1.00 EPS on March, 12.They anticipate $0.48 EPS change or 32.43 % from last quarter’s $-1.48 EPS. After having $-0.50 EPS previously, Melinta Therapeutics, Inc.’s analysts see 100.00 % EPS growth. The stock decreased 7.38% or $0.11 during the last trading session, […]